NFE2L2 and chronic kidney disease: Histone acetylation of NRF2 by CBP/p300 has been associated with increased promoter-specific DNA binding by NRF2 [19], while histone deacetylases repress NRF2 expression and have been shown to be elevated in some models of CKD [20,21].